# Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine

> **NCT02057315** · PHASE1,PHASE2 · COMPLETED · sponsor: **Achelios Therapeutics** · enrollment: 48 (actual)

## Conditions studied

- Migraine Headaches

## Interventions

- **DRUG:** ELS-M11
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02057315
- **Lead sponsor:** Achelios Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057315, "Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02057315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*